Clinical Microbiology Instrument and Reagent Market due to reach $5.8 Billion by 2026
Clinical microbiology holds a prominent role in the field of research and medicine, and support the fight against numerous infectious diseases along with antimicrobial resistance. High prevalence of infectious diseases and sexually transmitted diseases (STDs) will continue to drive the future of automated and rapid tests, as the need for quicker, higher volume and more accurate methods of testing gains significance.
Major players consist of
“Numerous analysts expects the market to grow at a CAGR of around 7% during 2021-2026.“
Bruker • Microbiology & Diagnostics ,
bioMérieux
Hologic, Inc.
Cepheid
BD
QIAGEN
Looking forward, numerous analysts expect the market to grow at a CAGR of around 7% from 2021 to 2026. Keeping in mind the uncertainties of COVID-19, the market is continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end-use sectors.
On a recruitment front, microbiology is a forever growing area with excellent innovation that arises YOY, if you are seeking a sales, application or marketing position for an organisation continuously offering market disruptive technology please do reach out to James Higgins.